イチバ　シンゴ   Ichiba Shingo   市場　晋吾    所属   医学部 医学科（東京女子医科大学病院）    職種   教授
論文種別	症例報告
言語種別	英語
査読の有無	査読あり
表題	Iliopsoas Hematoma in Patients Undergoing Venovenous ECMO.
掲載誌名	正式名：American journal of critical care : an official publication, American Association of Critical-Care Nurses 略　 称：Am J Crit Care ISSNコード：1937710X/10623264
掲載区分	国外
巻・号・頁	30(1),pp.55-63
著者・共著者	Taniguchi Hayato, Ikeda Tokuji, Takeuchi Ichiro, Ichiba Shingo
発行年月	2021/01
概要	BACKGROUND:Iliopsoas hematoma occasionally occurs in patients receiving anticoagulation therapy. It may be a life-threatening complication and can cause disseminated intravascular coagulation, which could develop into abdominal compartment syndrome. The incidence of and factors associated with iliopsoas hematoma during venovenous extracorporeal membrane oxygenation (ECMO) have not been well studied.OBJECTIVES:To describe the incidence of iliopsoas hematoma and associated factors among patients undergoing venovenous ECMO.METHODS:A retrospective cohort study was conducted at Nippon Medical School Hospital from April 2015 to October 2018. All patients (>18 years old) with iliopsoas hematoma received a diagnosis based on computed tomography.RESULTS:During the study period, 54 patients were supported with venovenous ECMO. Iliopsoas hematoma occurred in 8 of those patients (15%), none of whom had disseminated intravascular coagulopathy or abdominal compartment syndrome develop. Univariate analysis indicated that management of ECMO while the patient was awake and mobilization beyond sitting on the edge of the bed were significantly different (P < .05) in patients with and patients without iliopsoas hematoma. Mortality, however, did not differ significantly between the 2 groups.CONCLUSIONS:Our findings emphasize that recognizing factors associated with iliopsoas hematoma and detecting them early are crucial during venovenous ECMO in order to treat patients with iliopsoas hematoma appropriately.
DOI	10.4037/ajcc2021351
PMID	33385201